Completed NA INTERVENTIONAL 1-arm NCT04568395

Acute Effects of TCIG vs ECIG in PLWH

Acute Impact of Switching From Tobacco Cigarettes to E-Cigarettes in People Living With HIV

Sponsor: Tobacco Related Disease Research Program

Conditions E Cigarette Use HIV I Infection Inflammation Nicotine Use Disorder Oxidative Stress Qt Interval, Variation in Smoking Tobacco Smoking Vaping

Interventions ECIG TCIG sham control

Updated 7 times since 2020 Last updated: Oct 2, 2023 Started: Oct 1, 2020 Primary completion: May 8, 2023 Completion: May 8, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on E Cigarette Use and HIV I Infection, this trial is completed. The trial is conducted by Tobacco Related Disease Research Program and has accumulated 7 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2022 — Nov 2023 [monthly]

Recruiting NA
Jan 2021 — Jan 2022 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Oct 2020 — Nov 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tobacco Related Disease Research Program
University of California, Los Angeles

Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States